938 related articles for article (PubMed ID: 33580518)
1. Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
Hu S; Wang J; Zhang Y; Bai H; Wang C; Wang N; He L
J Med Virol; 2021 May; 93(5):3143-3151. PubMed ID: 33580518
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.
Zhang Y; Hu S; Wang J; Xue Z; Wang C; Wang N
Virology; 2021 Feb; 554():83-88. PubMed ID: 33387788
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
[TBL] [Abstract][Full Text] [Related]
4. Repositioning of histamine H
Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
Elife; 2020 Oct; 9():. PubMed ID: 33103998
[TBL] [Abstract][Full Text] [Related]
6. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
8. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
[TBL] [Abstract][Full Text] [Related]
9. Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach.
Lv Y; Wang S; Liang P; Wang Y; Zhang X; Jia Q; Fu J; Han S; He L
Anal Bioanal Chem; 2021 May; 413(11):2995-3004. PubMed ID: 33608752
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus.
Wang N; Han S; Liu R; Meng L; He H; Zhang Y; Wang C; Lv Y; Wang J; Li X; Ding Y; Fu J; Hou Y; Lu W; Ma W; Zhan Y; Dai B; Zhang J; Pan X; Hu S; Gao J; Jia Q; Zhang L; Ge S; Wang S; Liang P; Hu T; Lu J; Wang X; Zhou H; Ta W; Wang Y; Lu S; He L
Phytomedicine; 2020 Dec; 79():153333. PubMed ID: 32920291
[TBL] [Abstract][Full Text] [Related]
11. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
12. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
13. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro.
Zhan Y; Ta W; Tang W; Hua R; Wang J; Wang C; Lu W
Drug Dev Res; 2021 Dec; 82(8):1124-1130. PubMed ID: 33847382
[TBL] [Abstract][Full Text] [Related]
14. Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.
Veeramachaneni GK; Thunuguntla VBSC; Bobbillapati J; Bondili JS
J Biomol Struct Dyn; 2021 Jul; 39(11):4015-4025. PubMed ID: 32448098
[TBL] [Abstract][Full Text] [Related]
15. [Salvianolic acid B and its magnesium salt inhibit SARS-CoV-2 infection of Vero-E6 cells by blocking spike protein-mediated membrane fusion].
Yang C; Cheng C; Wang J; Chen K; Zhan J; Pan X; Xu X; Xu W; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):475-482. PubMed ID: 33963705
[TBL] [Abstract][Full Text] [Related]
16. Corilagin and 1,3,6-Tri-
Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
[TBL] [Abstract][Full Text] [Related]
17. Astemizole as a drug to inhibit the effect of SARS-COV-2 in vitro.
Wang X; Lu J; Ge S; Hou Y; Hu T; Lv Y; Wang C; He H
Microb Pathog; 2021 Jul; 156():104929. PubMed ID: 33932547
[TBL] [Abstract][Full Text] [Related]
18. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
19. Antiviral drugs suppress infection of 2019-nCoV spike pseudotyped virus by interacting with ACE2 protein.
Wang J; Zhang Y; Hu S; Bai H; Xue Z; Liu Y; Ma W
J Biochem Mol Toxicol; 2022 Feb; 36(2):e22948. PubMed ID: 34755435
[TBL] [Abstract][Full Text] [Related]
20. Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2.
Ge S; Lu J; Hou Y; Lv Y; Wang C; He H
Virology; 2021 Aug; 560():110-115. PubMed ID: 34052578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
